A generalized annular eruption with occasional vesicles.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 22508880)

Published in Arch Dermatol on April 01, 2012

Authors

Brian M Kleker1, Marigdalia K Ramirez-Fort, David Puchalsky, B Jack Longley, Andrew Swanson, John Zone

Author Affiliations

1: University of Wisconsin Hospitals and Clinics, Madison, USA.

Articles by these authors

Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol (2002) 20.87

Diagnosis of gastrointestinal stromal tumors: a consensus approach. Int J Surg Pathol (2002) 2.95

The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations. Blood (2002) 2.39

Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations. Hum Pathol (2002) 2.19

MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines. Cancer Res (2007) 2.08

Kikuchi's disease: case report and systematic review of cutaneous and histopathologic presentations. J Am Acad Dermatol (2008) 1.60

Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit. Exp Hematol (2003) 1.55

A novel biomarker for staging human prostate adenocarcinoma: overexpression of matriptase with concomitant loss of its inhibitor, hepatocyte growth factor activator inhibitor-1. Cancer Epidemiol Biomarkers Prev (2006) 1.41

Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis. Gastroenterology (2005) 1.32

Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease? FASEB J (2005) 1.28

Induction of autophagy and inhibition of melanoma growth in vitro and in vivo by hyperactivation of oncogenic BRAF. J Invest Dermatol (2010) 1.27

A randomized, double-blind, placebo-controlled phase 3 skin cancer prevention study of {alpha}-difluoromethylornithine in subjects with previous history of skin cancer. Cancer Prev Res (Phila) (2010) 1.21

Select cancer testes antigens of the MAGE-A, -B, and -C families are expressed in mast cell lines and promote cell viability in vitro and in vivo. J Invest Dermatol (2006) 1.21

A tool for self-assessment of communication skills and professionalism in residents. BMC Med Educ (2009) 1.13

Functional genomics uncovers three glucosyltransferases involved in the synthesis of the major sweet glucosides of Stevia rebaudiana. Plant J (2005) 1.13

Definitions and outcome measures for bullous pemphigoid: recommendations by an international panel of experts. J Am Acad Dermatol (2011) 1.04

Improving chronic kidney disease care in primary care practices: an upstate New York practice-based research network (UNYNET) study. J Am Board Fam Med (2008) 1.04

Familial urticaria pigmentosa: report of a family and review of the role of KIT mutations. Am J Dermatopathol (2013) 1.02

MAGE I transcription factors regulate KAP1 and KRAB domain zinc finger transcription factor mediated gene repression. PLoS One (2011) 0.93

The in vivo three-dimensional motion of the human lumbar spine during gait. Gait Posture (2008) 0.92

Pseudofolliculitis barbae: a dermatoscopic correlate. Dermatol Pract Concept (2013) 0.90

Angiosarcoma outcomes and prognostic factors: a 25-year single institution experience. Am J Clin Oncol (2014) 0.90

Cutaneous adenoid cystic carcinoma with perineural invasion treated by mohs micrographic surgery-a case report with literature review. J Oncol (2010) 0.89

Epigenetic control of MAGE gene expression by the KIT tyrosine kinase. J Invest Dermatol (2007) 0.87

Varicella zoster: an update on current treatment options and future perspectives. Expert Opin Pharmacother (2013) 0.85

Expression of angiopoietin-TIE system components in angiosarcoma. Mod Pathol (2013) 0.84

Atypical cellular disorders. Hematology Am Soc Hematol Educ Program (2002) 0.83

Identification of novel small molecules that inhibit protein-protein interactions between MAGE and KAP-1. Arch Biochem Biophys (2011) 0.82

Topical application of bleaching phenols; in-vivo studies and mechanism of action relevant to melanoma treatment. Melanoma Res (2011) 0.81

(V600E)Braf::Tyr-CreERT2::K14-Kitl mice do not develop superficial spreading-like melanoma: keratinocyte Kit ligand is insufficient to "translocate" (V600E)Braf-driven melanoma to the epidermis. J Invest Dermatol (2011) 0.81

Quantitative gene analysis of methylation and expression (Q-GAME) in fresh or fixed cells and tissues. Exp Dermatol (2014) 0.81

Desmoplastic trichoepithelioma, infiltrative/morpheaform BCC, and microcystic adnexal carcinoma: differentiation by immunohistochemistry and determining the need for Mohs micrographic surgery. Cutis (2010) 0.80

Zostavax : a subcutaneous vaccine for the prevention of herpes zoster. Expert Opin Biol Ther (2013) 0.80

Upregulation of PI3K/AKT/mTOR, FABP5 and PPARβ/δ in Human Psoriasis and Imiquimod-induced Murine Psoriasiform Dermatitis Model. Acta Derm Venereol (2016) 0.79

Eccrine Porocarcinoma Treated by Mohs Micrographic Surgery: Over 6-Year Follow-up of 12 Cases and Literature Review. Dermatol Surg (2015) 0.79

Immune responses in a mouse model of vitiligo with spontaneous epidermal de- and repigmentation. Pigment Cell Melanoma Res (2014) 0.78

KIT masters mast cells in kids, too. J Invest Dermatol (2010) 0.78

Hyperkeratotic necrobiosis lipoidica. Dermatol Pract Concept (2013) 0.75

How should we define celiac disease? J Pediatr Gastroenterol Nutr (2002) 0.75

Mohs surgical excision of a granular cell tumor with plexiform features on the arm of a 7-year-old child. Dermatol Surg (2010) 0.75

Thrombotic lymphocytic vasculitic reaction to intravenous immunoglobulin. J Am Acad Dermatol (2006) 0.75

Correspondence: The association between morphea profunda and monoclonal gammopathy: A case series. Dermatol Online J (2016) 0.75

Black spots in the returning traveler. Dermatol Online J (2013) 0.75

Generalized bullae in an infant. Arch Dermatol (2002) 0.75

C4d immunohistochemical stain is a sensitive method to confirm immunoreactant deposition in formalin-fixed paraffin-embedded tissue in bullous pemphigoid. J Cutan Pathol (2009) 0.75

TNF inhibitor induced alopecia: an unusual form of psoriasiform alopecia that breaks the Renbök mold. Dermatol Online J (2017) 0.75

Fractional CO2 Laser Pretreatment to Autologous Hair Transplantation and Phototherapy Improves Perifollicular Repigmentation in Refractory Vitiligo: A Randomized, Prospective, Half-Lesion, Comparative Study. Dermatol Surg (2016) 0.75

A 38-year-old woman with eyelid discoloration. Heliotrope-like manifestation of adult-onset Still disease (AOSD). Arch Dermatol (2012) 0.75

Serpiginous erythematous plaques on the feet. Arch Dermatol (2011) 0.75

Lips as red as blood: areca nut lip staining. JAMA Dermatol (2013) 0.75

Analysis of trial data for infliximab and golimumab: baseline C-reactive protein level and prediction of therapeutic response in patients with psoriatic arthritis. Arthritis Care Res (Hoboken) (2014) 0.75

Incidental Intravascular Histiocytosis During Mohs Surgery. Dermatol Surg (2016) 0.75

Neonatal pemphigus in an infant born to a mother with serologic evidence of both pemphigus vulgaris and gestational pemphigoid. J Am Acad Dermatol (2009) 0.75

Remission of refractory benign familial chronic pemphigus (hailey-hailey disease) with the addition of systemic cyclosporine. J Cutan Med Surg (2014) 0.75